Disc Medicine Inc. logo

Disc Medicine Inc.

IRON | NASDAQ
Chart Builder DCF Calculator
$68.49
-$1.04 (-1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$68.51
+$0.02 (+0.03%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$2.67B
Enterprise Value
$1.91B
Beta
2.05
Average Volume
515.73K
Shares Outstanding (Diluted)
38.69M
Shares Change YoY
10.45%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US2546041011

Price Performance

Price Change 1M
-14.9%
Price Change 3M
-2.8%
Price Change 6M
9.5%
Price Change YTD
-13.4%
Price Change 1Y
11.4%
Price Change 3Y
40.0%
Price Change 5Y
57.5%
1M CAGR (ann.)
-10.2%
1Y CAGR (ann.)
13.9%
5Y CAGR (ann.)
8.2%
All-Time CAGR
-6.2%

Valuation

PE Ratio
-10.38
Forward PE
N/A
PEG Ratio
0.29
Forward PEG
-1.26
PS Ratio
N/A
Forward PS
75.40
PB Ratio
4.08
P/FCF Ratio
-13.31
P/Adj. FCF Ratio
-10.82
P/OCF Ratio
-13.40
EV/Sales
N/A
EV/EBIT
-10.38
EV/EBITDA
-7.68
EV/FCF
-9.68
Earnings Yield
-9.6%
FCF Yield
-7.5%
Adj. FCF Yield
-9.2%

Financial Health

Net Cash
$716.22M
Total Debt
$1.52M
Cash & Short-Term Investments
$717.75M
Total Assets
$735.07M
Current Ratio
24.14
Quick Ratio
24.14
Debt / Equity Ratio
0.09
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-129.79
Interest Coverage
-75.81
Altman Z-Score
16.73
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-23.0%

Returns

Return on Assets
-33.5%
Return on Equity
-37.2%
Return on Invested Capital
-38.2%
Return on Capital Employed
-38.2%
Return on Tangible Assets
-33.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-29.4%
EPS CAGR 5Y
49.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-45.4%
FCF CAGR 5Y
-42.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
23.0%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$1.65
EPS Growth Est (next Q)
-6.8%
Revenue Est (next Q)
$1.88M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$106
Price Target Upside
54.8%

Cash Flow

Operating Cash Flow
$-197.54M
Free Cash Flow
$-197.58M
Adj. Free Cash Flow
$-243.03M
FCF Per Share
-$5.11
OCF Per Share
-$5.11
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-176K
Operating Income
$-269.27M
EBITDA
$-249.13M
Net Income
$-245.89M
EPS (Diluted)
-$6.60
Revenue / Employee
N/A
Profit / Employee
$-1.49M
Employees
165

© 2026 bestshares.com. All rights reserved.